530084-65-2Relevant academic research and scientific papers
Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD
McKinnell, R. Murray,Klein, Uwe,Linsell, Martin S.,Moran, Edmund J.,Nodwell, Matthew B.,Pfeiffer, Juergen W.,Thomas, G. Roger,Yu, Cecile,Jacobsen, John R.
, p. 2871 - 2876 (2014/06/10)
A multivalent approach focused on amine-based secondary binding groups was applied to the discovery of long-acting inhaled β2-agonists. Addition of amine moieties to the neutral secondary binding group of an existing β2-agonist serie
Aryl aniline beta2 adrenergic receptor agonists
-
, (2008/06/13)
The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic
